Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
11 pending office actions • 9 clients • 11 examiners • 11 art units • 0 of 11 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
EAGLE IP LIMITED focuses on Biotechnology & Pharmaceuticals and reports 11 pending office actions across 680 career applications. The pending workload and application total together show an active practice with a defined recorded portfolio.
The resolved allowance rate is 88.97%, and allowed matters average 2.25 office actions per allowance. Resolved matters frequently reach allowance, while successful cases generally involve more than one examination exchange. Practitioners can use the profile to frame prosecution planning around a favorable outcome measure and continued response activity.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (9%) |
| §101 + other | 1 (9%) |
| §103 only | 3 (27%) |
| §112 only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, UYEN M | 1 | 31.2% | +39.5% |
| JONES, CHRISTOPHER P | 1 | 76.1% | +24.8% |
| KUNEMUND, ROBERT M | 1 | 82.1% | +13.2% |
| LAU, JONATHAN S | 1 | 63.9% | -17.2% |
| MARTIN, PAUL C | 1 | 41.8% | +21.7% |
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
| HAYES, JONATHAN EDWARD | 1 | 36.3% | +23.5% |
| VANN-OJUEKAIYE, KENDRA RAYCHELL | 1 | 0.0% | +0.0% |
| TESKIN, FRED M | 1 | 89.6% | +7.9% |
| MPAMUGO, CHINYERE | 1 | 28.9% | +26.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350726 | Metadata-Based Diagnosis and Management System for Cardiovascular and Cerebrovascular Diseases | MPAMUGO, CHINYERE | 155d overdue |
| 19539091 | CONDUCTIVE, MULTILAYER STACKS FOR USE IN SILICON SOLAR CELLS AND PROCESSES FOR MAKING AND USING THE SAME INCLUDING LASER-BASED PROCESSES | TRAN, UYEN M | — |
| 18710633 | USES OF SPINEL-TYPE SINGLE CRYSTALS AS FERROELECTRICS AND RELAXOR FERROELECTRICS, ENERGY STORAGE MATERIAL AND RECHARGEABLE ENERGY STORAGE PRODUCT | KUNEMUND, ROBERT M | — |
| 18576751 | APPLICATION OF SPHERE SUBSTANCE IN PREPARATION OF INTRAVENOUS INJECTION | MARTIN, PAUL C | — |
| 18551601 | METHOD FOR IDENTIFYING DELETERIOUS GENETIC MUTATIONS | HAYES, JONATHAN EDWARD | — |
| 18463312 | METHODS AND KITS FOR ISOLATING TARGET NUCLEIC ACIDS BELOW A TARGET SIZE FROM A SAMPLE | VANN-OJUEKAIYE, KENDRA RAYCHELL | — |
| 18453011 | Ion-Conducting Membranes | TESKIN, FRED M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350726 | Metadata-Based Diagnosis and Management System for Cardiovascular and Cerebrovascular Diseases | MPAMUGO, CHINYERE | 155d overdue |
| 19539091 | CONDUCTIVE, MULTILAYER STACKS FOR USE IN SILICON SOLAR CELLS AND PROCESSES FOR MAKING AND USING THE SAME INCLUDING LASER-BASED PROCESSES | TRAN, UYEN M | — |
| 18817280 | Air Filter That Is Easy To Replace And Install | JONES, CHRISTOPHER P | — |
| 18710633 | USES OF SPINEL-TYPE SINGLE CRYSTALS AS FERROELECTRICS AND RELAXOR FERROELECTRICS, ENERGY STORAGE MATERIAL AND RECHARGEABLE ENERGY STORAGE PRODUCT | KUNEMUND, ROBERT M | — |
| 18576751 | APPLICATION OF SPHERE SUBSTANCE IN PREPARATION OF INTRAVENOUS INJECTION | MARTIN, PAUL C | — |
| 18399726 | ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | KATAKAM, SUDHAKAR | — |
| 18551601 | METHOD FOR IDENTIFYING DELETERIOUS GENETIC MUTATIONS | HAYES, JONATHAN EDWARD | — |
| Art Unit | Apps |
|---|---|
| 1726 | 1 |
| 1776 | 1 |
| 1714 | 1 |
| 1693 | 1 |
| 1653 | 1 |
| 1658 | 1 |
| 1685 | 1 |
| 1682 | 1 |
| 1762 | 1 |
| 3685 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19539091 | CONDUCTIVE, MULTILAYER STACKS FOR USE IN SILICON SOLAR CELLS AND PROCESSES FOR MAKING AND USING THE SAME INCLUDING LASER-BASED PROCESSES | Photara Inc. | TRAN, UYEN M | 1726 | §102§103 | Non-Final OA | — | Pending | Feb 13, 2026 |
| 18817280 | Air Filter That Is Easy To Replace And Install | Focus & Co., (Far East) Limited | JONES, CHRISTOPHER P | 1776 | §103 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18710633 | USES OF SPINEL-TYPE SINGLE CRYSTALS AS FERROELECTRICS AND RELAXOR FERROELECTRICS, ENERGY STORAGE MATERIAL AND RECHARGEABLE ENERGY STORAGE PRODUCT | UNIVERSITY OF MACAU | KUNEMUND, ROBERT M | 1714 | §102§103 | Final Rejection | — | Pending | May 16, 2024 |
| 18708217 | GLUCOHEXAOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND HAIR REGENERATION PREPARATION | UNIVERSITY OF MACAU | LAU, JONATHAN S | 1693 | §112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18576751 | APPLICATION OF SPHERE SUBSTANCE IN PREPARATION OF INTRAVENOUS INJECTION | Yunnan Key Laboratory Of Primate Biomedical Research | MARTIN, PAUL C | 1653 | §102§103§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18399726 | ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Sungening Biological Co., Ltd. | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18551601 | METHOD FOR IDENTIFYING DELETERIOUS GENETIC MUTATIONS | UNIVERSITY OF MACAU | HAYES, JONATHAN EDWARD | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18463312 | METHODS AND KITS FOR ISOLATING TARGET NUCLEIC ACIDS BELOW A TARGET SIZE FROM A SAMPLE | Phase Scientific International, Ltd. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103§112DP | Final Rejection | — | Pending | Sep 08, 2023 |
| 18453011 | Ion-Conducting Membranes | Greenlyzer US, Inc. | TESKIN, FRED M | 1762 | §103§112 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18350726 | Metadata-Based Diagnosis and Management System for Cardiovascular and Cerebrovascular Diseases | Serv Medical Pte. Ltd. | MPAMUGO, CHINYERE | 3685 | §101 | Non-Final OA | 155d overdue | Pending | Jul 11, 2023 |
| 17446307 | Use of GDF-15 in the Diagnosis and Treatment of Frailty and Conditions Associated with Altered Physiological Reserve, Physical Fitness and Exercise Capacity | The Chinese University of Hong Kong | ANDERSON-FEARS, KEENAN NEIL | 1687 | §103 | Final Rejection | — | Pending | Aug 30, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial89.0% of resolved applications prosecuted by Eagle Ip Limited were allowed, across 680 applications in USPTO records.
2.25 office actions per allowed application on average.
11 pending office actions as of October 2026, for 9 clients, before 11 examiners in 11 art units.
